In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Ampio Pharmaceuticals, Inc.. Trade Record

AMEX:AMPE Ampio Pharmaceuticals, Inc. stock gains 5.70% Exit Aug 3, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart AMPE Jul 20, 2018, priceSeries
About Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, which has completed Phase II clinical trials for diabetic macular edema. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.

Trade Information
Trade Type
LONG
ReliabilityScore™
95.50
Entry Date
Jul 20, 2018
Entry Price
2.63
Sell Date
Aug 3, 2018
Sell Price
2.78
Net Gain
5.70%
Hold Time
10 Trading Days